Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $3.6 million.

  • National Research's Capital Expenditures rose 12487.47% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year decrease of 504.26%. This contributed to the annual value of $15.4 million for FY2024, which is 209.77% down from last year.
  • National Research's Capital Expenditures amounted to $3.6 million in Q3 2025, which was up 12487.47% from $3.0 million recorded in Q2 2025.
  • National Research's Capital Expenditures' 5-year high stood at $5.3 million during Q2 2024, with a 5-year trough of $992000.0 in Q3 2021.
  • Its 5-year average for Capital Expenditures is $3.0 million, with a median of $3.0 million in 2025.
  • In the last 5 years, National Research's Capital Expenditures skyrocketed by 30151.21% in 2022 and then tumbled by 6429.53% in 2024.
  • Quarter analysis of 5 years shows National Research's Capital Expenditures stood at $1.7 million in 2021, then rose by 14.5% to $2.0 million in 2022, then surged by 91.76% to $3.8 million in 2023, then grew by 17.88% to $4.4 million in 2024, then fell by 19.24% to $3.6 million in 2025.
  • Its Capital Expenditures stands at $3.6 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.0 million for Q1 2025.